Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2022

May 24, 2022

32853_dirs_2022-05-23_9f4b2a4c-a289-4bbb-8fed-cdfafe87dd0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-05-20

Reporting Person: Kreger Bradley Allen (SVP, Global Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-20 Common Stock M 3125 Acquired 94433 Direct
2022-05-20 Common Stock M 2237 Acquired 96670 Direct
2022-05-20 Common Stock M 2391 Acquired 99061 Direct
2022-05-20 Common Stock M 25000 Acquired 124061 Direct
2022-05-20 Common Stock M 9527 Acquired 133588 Direct
2022-05-20 Common Stock F 14431 $2.05 Disposed 119157 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-20 Restricted Stock Units $ M 3125 Disposed Common Stock (3125.0) Direct
2022-05-20 Restricted Stock Units $ M 2237 Disposed Common Stock (2237.0) Direct
2022-05-20 Restricted Stock Units $ M 2391 Disposed Common Stock (2391.0) Direct
2022-05-20 Restricted Stock Units $ M 25000 Disposed Common Stock (25000.0) Direct
2022-05-20 Restricted Stock Units $ M 9527 Disposed Common Stock (9527.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F5: On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

F6: On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.